264 related articles for article (PubMed ID: 20967875)
21. Magnetic nanoparticle assisted molecular MR imaging.
Jun YW; Jang JT; Cheon J
Adv Exp Med Biol; 2007; 620():85-106. PubMed ID: 18217337
[TBL] [Abstract][Full Text] [Related]
22. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
Zhu L; Zhou Z; Mao H; Yang L
Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
[TBL] [Abstract][Full Text] [Related]
23. Are calcifying microvesicles another analogous substructure of calcifying nanoparticles?
Atughonu TC; Arja SB; Shiekh FA
Int J Nanomedicine; 2013; 8():4673-4. PubMed ID: 24353416
[No Abstract] [Full Text] [Related]
24. Magnetic nanoparticles as contrast agents in biomedical imaging: recent advances in iron- and manganese-based magnetic nanoparticles.
Felton C; Karmakar A; Gartia Y; Ramidi P; Biris AS; Ghosh A
Drug Metab Rev; 2014 May; 46(2):142-54. PubMed ID: 24754519
[TBL] [Abstract][Full Text] [Related]
25. The Design of Abnormal Microenvironment Responsive MRI Nanoprobe and Its Application.
Wang A; Han X; Qi W; Du S; Jiang Z; Tang X
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34067989
[TBL] [Abstract][Full Text] [Related]
26. Intrinsically Mn2+-Chelated Polydopamine Nanoparticles for Simultaneous Magnetic Resonance Imaging and Photothermal Ablation of Cancer Cells.
Miao ZH; Wang H; Yang H; Li ZL; Zhen L; Xu CY
ACS Appl Mater Interfaces; 2015 Aug; 7(31):16946-52. PubMed ID: 26196160
[TBL] [Abstract][Full Text] [Related]
27. Magnetic Nanoparticles as MRI Contrast Agents.
Avasthi A; Caro C; Pozo-Torres E; Leal MP; García-Martín ML
Top Curr Chem (Cham); 2020 May; 378(3):40. PubMed ID: 32382832
[TBL] [Abstract][Full Text] [Related]
28. Author's reply: To PMID 23450179.
Taupitz M; Schnorr J; Wagner S
Int J Nanomedicine; 2013; 8():4675-6. PubMed ID: 24383105
[No Abstract] [Full Text] [Related]
29. Magnetically engineered semiconductor quantum dots as multimodal imaging probes.
Jing L; Ding K; Kershaw SV; Kempson IM; Rogach AL; Gao M
Adv Mater; 2014 Oct; 26(37):6367-86. PubMed ID: 25178258
[TBL] [Abstract][Full Text] [Related]
30. Controlled self-assembling of gadolinium nanoparticles as smart molecular magnetic resonance imaging contrast agents.
Liang G; Ronald J; Chen Y; Ye D; Pandit P; Ma ML; Rutt B; Rao J
Angew Chem Int Ed Engl; 2011 Jul; 50(28):6283-6. PubMed ID: 21618367
[No Abstract] [Full Text] [Related]
31. Magnetoliposomes as multimodal contrast agents for molecular imaging and cancer nanotheragnostics.
Fattahi H; Laurent S; Liu F; Arsalani N; Vander Elst L; Muller RN
Nanomedicine (Lond); 2011 Apr; 6(3):529-44. PubMed ID: 21542690
[TBL] [Abstract][Full Text] [Related]
32. Adiabatic pulse preparation for imaging iron oxide nanoparticles.
Harris SS; Mao H; Hu XP
Magn Reson Med; 2012 Apr; 67(4):1133-7. PubMed ID: 22213366
[TBL] [Abstract][Full Text] [Related]
33. Magnetic nanoparticles applied in targeted therapy and magnetic resonance imaging: crucial preparation parameters, indispensable pre-treatments, updated research advancements and future perspectives.
Lin Y; Zhang K; Zhang R; She Z; Tan R; Fan Y; Li X
J Mater Chem B; 2020 Jul; 8(28):5973-5991. PubMed ID: 32597454
[TBL] [Abstract][Full Text] [Related]
34. Biocompatible Peptide-Coated Ultrasmall Superparamagnetic Iron Oxide Nanoparticles for In Vivo Contrast-Enhanced Magnetic Resonance Imaging.
Chee HL; Gan CRR; Ng M; Low L; Fernig DG; Bhakoo KK; Paramelle D
ACS Nano; 2018 Jul; 12(7):6480-6491. PubMed ID: 29979569
[TBL] [Abstract][Full Text] [Related]
35. The effects of particle shape and size on T2 relaxation in magnetic resonance imaging.
York JN; Albanese C; Rodriguez O; Le YC; Ackun-Farmmer M; Van Keuren E
J Biomed Nanotechnol; 2014 Nov; 10(11):3392-6. PubMed ID: 26000397
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, Functionalization, and Design of Magnetic Nanoparticles for Theranostic Applications.
Mosayebi J; Kiyasatfar M; Laurent S
Adv Healthc Mater; 2017 Dec; 6(23):. PubMed ID: 28990364
[TBL] [Abstract][Full Text] [Related]
37. Activatable interpolymer complex-superparamagnetic iron oxide nanoparticles as magnetic resonance contrast agents sensitive to oxidative stress.
Yoo E; Cheng HA; Nardacci LE; Beaman DJ; Drinnan CT; Lee C; Fishbein KW; Spencer RG; Fisher OZ; Doiron AL
Colloids Surf B Biointerfaces; 2017 Oct; 158():578-588. PubMed ID: 28750340
[TBL] [Abstract][Full Text] [Related]
38. Tailor-made PEG coated iron oxide nanoparticles as contrast agents for long lasting magnetic resonance molecular imaging of solid cancers.
Lazaro-Carrillo A; Filice M; Guillén MJ; Amaro R; Viñambres M; Tabero A; Paredes KO; Villanueva A; Calvo P; Del Puerto Morales M; Marciello M
Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110262. PubMed ID: 31761230
[TBL] [Abstract][Full Text] [Related]
39. Dual-Targeted Synthetic Nanoparticles for Cardiovascular Diseases.
Banik B; Surnar B; Askins BW; Banerjee M; Dhar S
ACS Appl Mater Interfaces; 2020 Feb; 12(6):6852-6862. PubMed ID: 31886643
[TBL] [Abstract][Full Text] [Related]
40. Photo-fluorescent and magnetic properties of iron oxide nanoparticles for biomedical applications.
Shi D; Sadat ME; Dunn AW; Mast DB
Nanoscale; 2015 May; 7(18):8209-32. PubMed ID: 25899408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
